20 October 2021 : Clinical Research
Analysis of Characteristics of Patients with Non-ST-Segment Elevation Myocardial Infarction by Cardiac Magnetic Resonance Imaging
Shujuan Dong1ACE, Yunbo Liu2E, Wenjing Sun1BE, Chunqiu Wang3BD, Yan Wang3C, Wenbo Zhao1F, Shenghui Zhao1F, Yingjie Chu1G*DOI: 10.12659/MSM.933220
Med Sci Monit 2021; 27:e933220
Table 6 Procedural characteristics and medical therapy of the studied population.
| ST-segment elevation group (n=120) | ST-segment normal group (n=52) | ST-segment depression group (n=76) | P | |
|---|---|---|---|---|
| Pre-procedure TIMI flow ≤II, n (%) | 114 (95) | 47 (90) | 58 (76) | 0.43 |
| Post procedure TIMI flow III, n (%) | 106 (88) | 48 (92) | 72 (95) | 0.29 |
| Door-to-balloon time (h) | 62 (53–90) | 67 (59–90) | 68 (57–90) | 0.68 |
| Stent implantation, n (%) | 103 (86) | 42 (81) | 65 (86) | 0.55 |
| Antiplatelet therapy, n (%) | 110 (92) | 48 (92) | 68 (89) | 0.37 |
| ACE-I or ARB, n (%) | 98 (82) | 44 (85) | 62 (82) | 0.76 |
| Beta Blocker, n (%) | 95 (79) | 42 (81) | 64 (84) | 0.89 |
| Statin, n (%) | 110 (92) | 48 (92) | 68 (89) | 0.91 |
| Data are numbers (percentages). TIMI – thrombolysis in myocardial infarction. | ||||